Arjan H Schoneveld
Overview
Explore the profile of Arjan H Schoneveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
de Kleijn D, Moll F, Hellings W, Ozsarlak-Sozer G, de Bruin P, Doevendans P, et al.
Arterioscler Thromb Vasc Biol
. 2009 Dec;
30(3):612-9.
PMID: 20018935
Objective: Atherosclerotic cardiovascular disease is a major burden to health care. Because atherosclerosis is considered a systemic disease, we hypothesized that one single atherosclerotic plaque contains ample molecular information that...
22.
Vink A, Schoneveld A, Lamers D, Houben A, van der Groep P, van Diest P, et al.
Atherosclerosis
. 2007 Jul;
195(2):e69-75.
PMID: 17606258
Objective: Angiogenesis and inflammation are important features in atherosclerotic plaque destabilization. The transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a key regulator of angiogenesis and is also involved in...
23.
Sluijter J, Pulskens W, Schoneveld A, Velema E, Strijder C, Moll F, et al.
Stroke
. 2005 Dec;
37(1):235-9.
PMID: 16339461
Background And Purpose: We studied matrix metalloproteinases (MMP) 2, 8, and 9 and extracellular matrix metalloproteinase inducer (EMMPRIN) levels in relation to carotid atherosclerotic plaque characteristics. Methods: Carotid atherosclerotic plaques...
24.
van Oostrom O, Velema E, Schoneveld A, de Vries J, de Bruin P, Seldenrijk C, et al.
Cardiovasc Pathol
. 2005 May;
14(3):126-34.
PMID: 15914297
Objective: The extent of atherosclerotic plaque burden and the incidence of atherosclerosis-related cardiovascular events accelerate with increasing age. The composition of the plaque is associated with plaque thrombosis and acute...
25.
Verhoeven B, Velema E, Schoneveld A, de Vries J, de Bruin P, Seldenrijk C, et al.
Eur J Epidemiol
. 2005 Feb;
19(12):1127-33.
PMID: 15678794
In clinical practice, biological markers are not available to routinely assess the progression of atherosclerotic disease or the development of restenosis following endarterectomy or catheter based interventions. Endarterectomy procedures provide...
26.
Oude Nijhuis M, van der Graaf Y, Melief M, Schoneveld A, de Kleijn D, Laman J, et al.
Atherosclerosis
. 2004 Apr;
173(2):245-51.
PMID: 15064098
Objective: Atherosclerosis may lead to acute clinical events by rupture of a vulnerable atherosclerotic plaque. Previously, we demonstrated that peptidoglycan (PGN), a major cell wall component of gram-positive bacteria that...
27.
Hollestelle S, de Vries M, van Keulen J, Schoneveld A, Vink A, Strijder C, et al.
Circulation
. 2003 Dec;
109(3):393-8.
PMID: 14699006
Background: Toll-like receptor 4 (Tlr4) is the receptor for exogenous lipopolysaccharides (LPS). Expression of endogenous Tlr4 ligands, heat shock protein 60 (Hsp60) and extra domain A of fibronectin, has been...
28.
Vink A, Schoneveld A, Borst C, Pasterkamp G
J Vasc Surg
. 2002 Dec;
36(6):1194-8.
PMID: 12469038
Background: Atherosclerotic luminal narrowing is caused by plaque growth and arterial remodeling. In peripheral arteries, a role for constrictive remodeling in luminal narrowing has been recognized, but the impact on...
29.
Vink A, Schoneveld A, van der Meer J, van Middelaar B, Sluijter J, Smeets M, et al.
Circulation
. 2002 Oct;
106(15):1985-90.
PMID: 12370224
Background: Inflammation plays an important role in atherogenesis. The toll-like receptor 4 (TLR4) is the receptor for bacterial lipopolysaccharides and also recognizes cellular fibronectin and heat shock protein 60, endogenous...
30.
Laman J, Schoneveld A, Moll F, van Meurs M, Pasterkamp G
Am J Cardiol
. 2002 Jul;
90(2):119-23.
PMID: 12106839
Peptidoglycan (PG) is a major component of the cell wall of gram-positive bacteria that is abundantly present in all human mucosa. PG is a functional lipopolysaccharide analog that binds to...